Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
12,805,677
Total 13F shares
14,276,867
Share change
+7,008,758
Total reported value
$5,439,564
Put/Call ratio
0.61%
Price per share
$0.38
Number of holders
44
Value change
+$2,030,904
Number of buys
19
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 76152G100?
CUSIP 76152G100 identifies RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
HIGHBRIDGE CAPITAL MANAGEMENT LLC
13D/G
9.9%
8,000,000
$3,120,000 $0 30 Jun 2025
VANGUARD GROUP INC
13F
Company
14%
1,804,092
$1,721,103 31 Mar 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
12%
1,534,317
$1,463,432 31 Mar 2025
13F
TANG CAPITAL MANAGEMENT LLC
13D/G 13F
Company
4.8%
3,399,975
$1,325,990 -$199,028 30 Jun 2025
Schonfeld Strategic Advisors LLC
13D/G 13F
Company
2.8%
1,314,915
$1,157,125 $0 31 Dec 2024
DIADEMA PARTNERS LP
13F
Company
5.1%
650,723
$620,660 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
3.3%
419,139
$399,829 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
1.8%
231,450
$220,757 31 Mar 2025
13F
UBS Group AG
13F
Company
1.7%
223,541
$213,258 31 Mar 2025
13F
MARSHALL WACE, LLP
13F
Company
1.7%
216,498
$205,673 31 Mar 2025
13F
Private Advisor Group, LLC
13F
Company
1.6%
200,000
$190,760 31 Mar 2025
13F
Persistent Asset Partners Ltd
13F
Company
1.3%
160,310
$152,904 31 Mar 2025
13F
Avidity Partners Management LP
13F
Company
1.1%
138,000
$131,624 31 Mar 2025
13F
STATE STREET CORP
13F
Company
0.99%
126,700
$120,846 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
0.89%
114,013
$108,746 31 Mar 2025
13F
EMC Capital Management
13F
Company
1%
127,915
$83,000 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.56%
71,379
$68,081 31 Mar 2025
13F
NewEdge Advisors, LLC
13F
Company
0.48%
60,900
$58,086 31 Mar 2025
13F
Focus Partners Wealth
13F
Company
0.47%
60,000
$57,228 31 Mar 2025
13F
AVANTAX ADVISORY SERVICES, INC.
13F
Company
0.45%
57,500
$54,844 31 Mar 2025
13F
BluePointe Capital Management, LLC
13F
Company
0.37%
47,185
$45,005 31 Mar 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.35%
44,916
$42,841 31 Mar 2025
13F
Quadrature Capital Ltd
13F
Company
0.3%
38,941
$36,885 31 Mar 2025
13F
Sound Income Strategies, LLC
13F
Company
0.23%
30,000
$28,614 31 Mar 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.16%
20,670
$19,715 31 Mar 2025
13F
DRIVE WEALTH MANAGEMENT, LLC
13F
Company
0.16%
20,000
$19,076 31 Mar 2025
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.14%
17,392
$17,000 31 Mar 2025
13F
Cornerstone Select Advisors, LLC
13F
Company
0.14%
17,500
$16,692 31 Mar 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.12%
15,134
$14,435 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.12%
15,000
$14,307 31 Mar 2025
13F
Jump Financial, LLC
13F
Company
0.1%
12,600
$12,020 31 Mar 2025
13F
NRI Wealth Management LC
13F
Company
0.1%
12,380
$11,808 31 Mar 2025
13F
Virtu Financial LLC
13F
Company
0.09%
11,298
$11,000 31 Mar 2025
13F
Sanctuary Advisors, LLC
13F
Company
0.09%
11,000
$10,492 31 Mar 2025
13F
INSIGNEO ADVISORY SERVICES, LLC
13F
Company
0.08%
10,000
$9,538 31 Mar 2025
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0.07%
9,299
$8,869 31 Mar 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.06%
8,247
$7,866 31 Mar 2025
13F
IFP Advisors, Inc
13F
Company
0.04%
4,900
$4,673 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.03%
4,120
$3,930 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
3,357
$3,202 31 Mar 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
3,000
$2,861 31 Mar 2025
13F
Caitong International Asset Management Co., Ltd
13F
Company
0.01%
1,215
$1,159 31 Mar 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
1,500
$1,000 31 Mar 2025
13F
Activest Wealth Management
13F
Company
0.01%
1,000
$954 31 Mar 2025
13F
JONES FINANCIAL COMPANIES LLLP
13F
Company
0.01%
840
$848 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
352
$335 31 Mar 2025
13F
TD Waterhouse Canada Inc.
13F
Company
0%
495
$306 31 Mar 2025
13F
Tradewinds Capital Management, LLC
13F
Company
0%
250
$239 31 Mar 2025
13F
FMR LLC
13F
Company
0%
200
$191 31 Mar 2025
13F
BARCLAYS PLC
13F
Company
0%
6
$6 31 Mar 2025
13F

Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q2 2025

As of 30 Jun 2025, REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,276,867 shares. The largest 10 holders included DIADEMA PARTNERS LP, ARMISTICE CAPITAL, LLC, HEIGHTS CAPITAL MANAGEMENT, INC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, 683 Capital Management, LLC, Persistent Asset Partners Ltd, GEODE CAPITAL MANAGEMENT, LLC, SIMPLEX TRADING, LLC, and SABBY MANAGEMENT, LLC. This page lists 45 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
47
Q2 2025 holders
44
Holder diff
-3
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .